ARTHROGENIC ALPHAVIRUS VACCINE
- Summary
- Vaccine comprising live attenuated recombinant alphavirus vaccine comprising mutated capsid protein
- Technology Benefits
- Vaccine to prevent alphavirus infections such as Chikungunya and Ross River Fever.
- Technology Application
- Vaccine - disease prevention
- Detailed Technology Description
- This invention relates to a vaccine comprising live attenuated recombinant alphavirus comprising mutated capsid protein as well as a method for preventing a subject from contracting an alphaviral infection that would otherwise produce clinical signs of disease. In an embodiment that mutated capsid protein is Chikungunya virus capsid protein having mutated nucleolar localisation signal/sequence.
- Type of Cooperation
- Licensing
- Application Date
- 25/05/2017 00:00:00
- Application No.
- PCT/AU2017/050489
- Country/Region
- USA
For more information, please click Here